Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer

Cell Stem Cell
Michael D BrooksMax S Wicha

Abstract

Cellular heterogeneity represents one of the greatest challenges in cancer therapeutics. In many malignancies, this heterogeneity is generated during tumor evolution through a combination of genetic alterations and epigenetic events that recapitulate normal developmental processes including stem cell self-renewal and differentiation. Many, if not most, tumors display similar hierarchal organization, at the apex of which are "stem-like cells" that drive tumor growth, mediate metastasis, and contribute to treatment resistance. Using breast cancer as a model, we discuss how an improved understanding of tumor cellular heterogeneity and plasticity may lead to development of more effective therapeutic strategies.

References

Sep 17, 1999·The American Journal of Pathology·A J ManiotisM J Hendrix
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
May 21, 2003·Genes & Development·Gabriela DontuMax S Wicha
Sep 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Celina G KleerArul M Chinnaiyan
Oct 2, 2003·Journal of the National Cancer Institute·William D FoulkesLars A Akslen
Mar 31, 2004·Proceedings of the National Academy of Sciences of the United States of America·Charlotte KuperwasserRobert A Weinberg
Nov 19, 2004·Nature·Sheila K SinghPeter B Dirks
Dec 3, 2005·Cancer Research·Anne T CollinsNorman J Maitland
Jan 6, 2006·Nature·John StinglConnie J Eaves
Jan 7, 2006·Nature·Mark ShackletonJane E Visvader
Dec 21, 2006·Journal of the National Cancer Institute·Tiffany M PhillipsFrank Pajonk
Feb 7, 2007·Cancer Research·Chenwei LiDiane M Simeone
Oct 4, 2007·Proceedings of the National Academy of Sciences of the United States of America·Jiangbing ZhouYing Zhang
Dec 1, 2007·Cell Death and Differentiation·A EramoR De Maria
Mar 28, 2008·The New England Journal of Medicine·Soonmyung PaikNorman Wolmark
Apr 9, 2008·Proceedings of the National Academy of Sciences of the United States of America·Kathryn B HorwitzCarol A Sartorius
May 1, 2008·Journal of the National Cancer Institute·Xiaoxian LiJenny C Chang
Sep 12, 2008·Nature Reviews. Cancer·Jane E Visvader, Geoffrey J Lindeman
Nov 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Thehang H LuuGeorge Somlo
Aug 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Chad J CreightonJenny C Chang
Oct 26, 2010·Molecular Cancer Therapeutics·Hamed Al-HussainiSrikala S Sridhar
Nov 26, 2010·Proceedings of the National Academy of Sciences of the United States of America·Christine M FillmoreCharlotte Kuperwasser
Dec 24, 2010·PloS One·Kevin LederFranziska Michor
Jan 26, 2011·Proceedings of the National Academy of Sciences of the United States of America·Yasushi SodaInder M Verma
Feb 10, 2011·The Oncologist·Charles M Perou
Jun 29, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A GoldhirschUNKNOWN Panel members
Aug 16, 2011·Molecular Cancer Research : MCR·Dianbo YaoSonglin Peng

❮ Previous
Next ❯

Citations

Feb 16, 2016·Stem Cell Reports·Javier A MenendezTomás Alarcón
May 4, 2016·Current Stem Cell Reports·Efraín A Cermeño, Andrés J García
Dec 26, 2015·Breast Cancer Research and Treatment·Tala AchkarShannon Puhalla
Mar 10, 2016·Briefings in Functional Genomics·Marion A SalvadorChristophe Ginestier
Jun 1, 2016·The Veterinary Journal·Lisa Y Pang, David J Argyle
May 6, 2016·Frontiers in Pharmacology·Bing LuWei Zhao
May 9, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Gholamreza KhamisipourMohammad Hojjat-Farsangi
May 26, 2016·Breast Cancer Research : BCR·Maria Peiris-PagèsMichael P Lisanti
Jul 16, 2016·The British Journal of Radiology·Richard P Hill
Aug 9, 2016·Pharmacology & Therapeutics·John P Harrelson, Michael W Lee
Jul 13, 2016·Endocrine-related Cancer·Maria Theresa E MontalesRosalia C M Simmen
Aug 18, 2016·Cellular and Molecular Life Sciences : CMLS·Fang YangXiaoxiang Guan
Aug 17, 2016·Endocrine-related Cancer·Kiranjit K DhillonChristopher J Lord
Oct 17, 2016·EBioMedicine·Brett A MorrisPatricia J Keely
Mar 30, 2017·Nature·Mariko ShimokawaToshiro Sato
Jun 1, 2017·Analytical Chemistry·Maria Elena GallinaGuillem Pratx
Jun 16, 2017·Cell Proliferation·D A D CâmaraI Kerkis
Feb 17, 2018·Carcinogenesis·Bruna Corominas-FajaJavier A Menendez
Dec 2, 2017·International Journal of Molecular Sciences·Marta Prieto-VilaTakahiro Ochiya
Jul 20, 2017·International Journal of Cancer. Journal International Du Cancer·Pritish NilenduNilesh Kumar Sharma
Dec 12, 2017·The Journal of Clinical Investigation·Qi SunJay S Desgrosellier
Oct 1, 2016·Cancer Informatics·Sunny TianShuying Sun
Apr 7, 2017·Disease Models & Mechanisms·Ingunn HolenKaren Blyth
Jan 30, 2019·Genes & Development·Honghong ZhangChonghui Cheng
Mar 12, 2019·PLoS Computational Biology·Margaret P ChapmanClaire J Tomlin
Mar 22, 2019·International Journal of Radiation Biology·Claudia PeitzschMichael Baumann
Jul 23, 2019·Chemical Communications : Chem Comm·Wenxiang LiLiang Hu
Sep 4, 2019·Nature Communications·Sung Pil HongLuca Magnani
Jan 23, 2020·Stem Cell Reviews and Reports·Plabon Kumar DasFarhadul Islam
Dec 19, 2019·The Oncologist·Justin LathiaDaniela Matei

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Related Papers

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
V Almendro, G Fuster
© 2021 Meta ULC. All rights reserved